Goddres Pharmaceuticals Private Limited, a active private limited company, was established on 12 January 2010 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232MH2010PTC217851. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹9.50 M.
It upholds a compliant status. Employing 248 professional, Its leadership includes Sanjay Kumar (Director), Dev Kumar Chatterjee (Director), Dhirendra Deo (Director). Past directors included Sanjay Kumar, Rajesh Dewan, Dev Kumar Chatterjee. It holds ₹11.94 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Unit No.304, Third Floor, A Wing, Western Edge-Ii, Near Western Express Highway, Boriwali (, East), Mumbai, Maharashtra, 400066.
U24232MH2010PTC217851
217851
12 January 2010
₹1.00 Cr
₹9.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Goddres Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Kumar | Director | 01 Aug 2012 | Current |
| Dev Kumar Chatterjee | Director | 17 May 2013 | Current |
| Dhirendra Deo | Director | 05 Feb 2010 | Current |
| Rajesh Dewan | Director | 25 Feb 2016 | Current |
| Gourango Mukherjee | Managing Director | 05 Feb 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Apr 2012 | Past |
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Director | 06 Nov 2012 | Past |
| Pramod Abcsdd | Director | 03 Feb 2025 | Past |
| Pramod Abcsdd | Director | 03 Apr 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Goddres Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 37.15% increase. The company also saw a substantial improvement in profitability, with a 46.45% increase in profit. The company's net worth Soared by an impressive increase of 12.29%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Goddres Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹119,375,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Aug 2022 | Others | ₹2.40 M | Open |
| 18 Jan 2021 | Others | ₹6.98 M | Open |
| 24 Sep 2012 | Others | ₹11.00 Cr | Open |
Explore comprehensive loan charge details -
Goddres Pharmaceuticals has a workforce of 248 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Goddres Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Goddres Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others of Rs. 11.00 Cr registered on 24 Sep 2012 with Charge ID 10377496 was modified on 19 Dec 2024. was recorded as a recent event.
The activity Goddres Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Goddres Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
A charge with Others amounted to Rs. 0.24 Cr with Charge ID 100618805 was registered on 29 Aug 2022. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 0.70 Cr with Charge ID 100420925 was registered on 18 Jan 2021. was completed.
Progress on Rajesh Dewan was appointed as a Director was appointed as a Director on 25 Feb 2016 & has been associated with this company since 9 years 9 months . was documented.
The CIN of Goddres Pharmaceuticals Private Limited is U24232MH2010PTC217851.
Goddres Pharmaceuticals Private Limited is headquartered at Unit No.304, Third Floor, A Wing, Western Edge-Ii, Near Western Express Highway, Boriwali (, East), Mumbai, Maharashtra, 400066.
Goddres Pharmaceuticals Private Limited was incorporated on 12 January 2010.
The current directors of Goddres Pharmaceuticals Private Limited are
The primary industry of Goddres Pharmaceuticals Private Limited is Trade.
Goddres Pharmaceuticals Private Limited is unlisted.
The authorized capital of Goddres Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹9.50 M.
The compliance status of Goddres Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX